PTEN, PIK3CA, p-AKT, and p-p70S6K Status
Francisco J. Esteva(The University of Texas MD Anderson Cancer Center), Dihua Yu(The University of Texas MD Anderson Cancer Center)
Cited by 285
Related Papers
Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy
|Journal of Clinical Oncology|2011|211
ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells
|Cancer Research|2006|200
EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation
|Nature Communications|2022|190
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival
|Cancer Research|2009|175
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells
|Breast Cancer Research|2010|137